Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
Per Winkel, J Hilden, Jørgen Fischer Hansen, Per Hildebrandt, Jens Kastrup, Hans Jørn Kolmos, Erik Kjøller, Christian M. Jespersen, Christian Gluud, GB Jensen, Group CLARICOR Trial
Dive into the research topics of 'Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?'. Together they form a unique fingerprint.